Nasze serwisy używają informacji zapisanych w plikach cookies. Korzystając z serwisu wyrażasz zgodę na używanie plików cookies zgodnie z aktualnymi ustawieniami przeglądarki, które możesz zmienić w dowolnej chwili. Więcej informacji odnośnie plików cookies.

Obowiązek informacyjny wynikający z Ustawy z dnia 16 listopada 2012 r. o zmianie ustawy – Prawo telekomunikacyjne oraz niektórych innych ustaw.

Wyłącz komunikat

 
 

Logowanie

Logowanie za pomocą Centralnej Usługi Uwierzytelniania PRz. Po zakończeniu pracy nie zapomnij zamknąć przeglądarki.

Modern Management Review (dawna nazwa: Zarządzanie i Marketing)

Modern Management Review
(dawna nazwa: Zarządzanie i Marketing)
23 (4/2016), DOI: 10.7862/rz.2016.mmr.46

THE CAPITAL MARKET AS A SOURCE OF FINANCING FOR SMALL INNOVATIVE COMPANIES IN THE MEDICAL INDUSTRY

Petre ILTCHEV, Anna PIECHOTA, Remigiusz KOZŁOWSKI, Michał MARCZAK
Submitted by: Paweł Perz

DOI: 10.7862/rz.2016.mmr.46

Abstract

The objective of the paper is to present the possibilities of financing the development of companies in the pharmaceutical, biotechnological, and medical sectors through the capital market. The trading prices of selected companies on the Polish stock exchanges (NewConnect and WSE) are discussed. Furthermore, the work analyzes the evolution of the WSE in the years 2007–2015 with a particular focus on the trading volumes and the maximum and minimum prices of the stocks of selected biotechnological and medical companies between January 2015 and April 2016. Using DbNotowania software from Statica, the selected companies were analyzed visually to identify abnormal price changes. Data were obtained from the at-skaner.pl database, normalized, and imported to Microsoft Access for more detailed analysis. It was concluded that the WSE may play a more prominent role in the development of innovative biotechnological, pharmaceutical, and medical companies if the changes recommended in this paper are implemented. Given the tendency towards capital market consolidation, it is logical that following an IPO on less liquid markets, companies will gradually try to transition to the more liquid ones. It would be advisable for small innovative companies to attract the attention of recommendation-issuing companies such as Edison Investment Research. The government should encourage individual and institutional investors to participate and finance the Polish capital market by appropriate regulations and tax exemptions.

Full text (pdf)

References

  1. Chau Hy. 2012. The VIX and its applications in the market. Online:http://citeseerx.ist.psu.edu/ viewdoc/download?doi=10.1.1.474.5304&rep=rep1&type=pdf Accessed, 20.03.2016.
  2. Cymcyk Paweł. 2016. Udział inwestorów w handlu na GPW. DNA Rynków. 29 02 2016 roku. Online: http://dnarynkow.com.2016/02/29/inwestor-gatunek-zagrozony Accessed, 20.03.2016
  3. Detrixhe John. 2016. Exchanges Talk Marriage While Their Nations Contemplate Divorce. Online: http://www.bloomberg.com/news/articles/2016-02-24/exchanges-talk-marriage-while-their-nations-contemplate-divorce. Accessed February 24, 2016.
  4. Detrixhe John. 2016. London Stock Exchange, Deutsche Boerse Agree on Merger. Bloomberg. March 16, 2016. http://www.bloomberg.com/news/articles/2016-03-16/lse-agrees-to-merge-with-german-rival-to-create-european-titan Accessed 17.03.2016.
  5. Goedhart Marc, Koller Tim, Wessels David. 2016. Valuing high-tech companies. McKinesy. Online: http://www.mckinsey.com/Business-Functions/Strategy-and-Corporate-Finance/Our-Insights/Valuing-high-tech-companies?cid=other-eml-alt-mip-mck-oth-1602. Accessed 24.02.2016.
  6. ISBnews – Biznes. GPW przedłuża okres niższych opłat transakcyjnych. 29 Mar 2016, Online http://stooq.pl/n/?f=1030680 Accessed, 29.03.2016.
  7. Kahn Jeremy, Satariano Adam. 2016. Brexit Nerves Cost This London Tech Startup $142,00i0 Already. Bloomberg. March 9, 2016. Online http://www.bloomberg.com/news/articles/2016-03-09/-brexit-nerves-cost-this-london-tech-startup-142-000-already. Accessed, 27.03.2016.
  8. Kowalik Filip. 2015. Kto pomaga inwestorom na GPW tracić pieniądze. Forbes. 06.11.2015. Online: http://www.forbes.pl/inwestorzy-na-gpw-traca-pieniadze-warszawska-gielda-w-kryzysie,artykuly,199892,1,1.html. Accessed 24.02.2016.
  9. Manda Kiran. 2010. Stock Market Volatility during the 2008 Financial Crisis. The Leonard N. Stern School of Business. Glucksman Institute for Research in Securities Markets. April 1, 2010. Online: http://www.stern.nyu.edu/sites/default/files/assets/documents/uat_024308.pdf Accessed, 20.03.2016.
  10. Orelli Brian. 2016. 9 Things you need to know about biosimilar drugs. The Motley Fool. Online:http://www.nasdaq.com/article/9-things-you-need-to-know-about-biosimilar-drugs-cm598394. Accessed, 27.03.2016.
  11. Steinki Olivier, Mohammad Ziad. 2015. Common metrics for performance evaluation: overview of popular performance measurement ratios. Evoltiq. Online https://www.academia.edu/ 16470851/Common_Metrics_for_Performance_Evaluation_Overview_of_Popular_Performance_Measurement_Ratios Accessed, 20.03.2016.
  12. Stopka, Michał. 2016. Rekordowa dziura budżetowa i nadwyżka: Polska i Niemcy. Online: http://www.michalstopka.pl/rekordowa-dziura-budzetowa-i-nadwyzka-polska-i-niemcy. Accessed 24.02.2016.
  13. Takeo Yuko, Hasegawa Toshiro. 2016. Japanese IPOs Struggle to Gain Ground. BloombergBusiness. March 27, 2016. Online: http://www.bloomberg.com/news/articles/2016-03-27/woes-descend-on-japanese-ipos-as-stocks-tank-at-start-of-trading. Accessed, 27.03.2016.

About this Article

TITLE:
THE CAPITAL MARKET AS A SOURCE OF FINANCING FOR SMALL INNOVATIVE COMPANIES IN THE MEDICAL INDUSTRY

AUTHORS:
Petre ILTCHEV (1)
Anna PIECHOTA (2)
Remigiusz KOZŁOWSKI (3)
Michał MARCZAK (4)

AUTHORS AFFILIATIONS:
(1) PhD,  Public Health Department, Health Sciences Faculty, Medical University of Lodz
(2) PhD, Institute of Finance, Faculty of Economics and Sociology, University of Lodz
(3) Prof. , DSc, PhD, Eng.,Department of Logistics, Faculty of Management, University of Lodz
(4) PhD, Associate Prof. UMED of Lodz, Health Care Policy Department, Health Sciences Faculty, Medical University of Lodz

SUBMITTED BY:
Paweł Perz

JOURNAL:
Modern Management Review
23 (4/2016)

KEY WORDS AND PHRASES:
Polish biotechnology companies, Polish capital market, Financing Small innovative companies

FULL TEXT:
http://doi.prz.edu.pl/pl/pdf/zim/259

DOI:
10.7862/rz.2016.mmr.46

URL:
http://dx.doi.org/10.7862/rz.2016.mmr.46

COPYRIGHT:
Publishing House of Rzeszow University of Technology Powstańców Warszawy 12, 35-959 Rzeszow

POLITECHNIKA RZESZOWSKA im. Ignacego Łukasiewicza; al. Powstańców Warszawy 12, 35-959 Rzeszów
tel.: +48 17 865 11 00, fax.: +48 17 854 12 60
Administrator serwisu: